Anti-IL6 treatment of serious COVID-19 disease: A monocentric retrospective experience

COVID-19 is causing a high influx of patients suffering from serious respiratory complications leading the necessity to find effective therapies. These patients seem to present with cytokine perturbation and high levels of IL6. Tocilizumab and sarilumab could be effective in this condition. We retro...

Descripción completa

Detalles Bibliográficos
Autores principales: Castelnovo, Laura, Tamburello, Antonio, Lurati, Alfredo, Zaccara, Eleonora, Marrazza, Maria Grazia, Olivetti, Micol, Mumoli, Nicola, Mastroiacovo, Daniela, Colombo, Daniele, Ricchiuti, Elisabetta, Vigano’, Paolo, Paola, Faggioli, Mazzone, Antonino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793456/
https://www.ncbi.nlm.nih.gov/pubmed/33429732
http://dx.doi.org/10.1097/MD.0000000000023582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793456/
https://www.ncbi.nlm.nih.gov/pubmed/33429732
http://dx.doi.org/10.1097/MD.0000000000023582

Ejemplares similares